All Episodes

From Biology to Best Practice: Sequencing Current and Emerging Therapies in EGFR-Mutated NSCLC Beyond Progression

Adapting to Evolution for Second-Line Treatment in EGFR-Mutated Advanced NSCLC: Understanding Tumor Biology to Elevate the Therapeutic Strategy

Designing the Foundation: Optimizing First-Line Therapy for EGFR-Mutated Advanced NSCLC

Practical Conversations on PAH Care: Risk-Based Strategies for Specialists in the Community

The Promise of Oral Therapy for HER2-Mutated NSCLC: Unlocking New Treatment Opportunities With a Familiar Target

Reducing Cardiometabolic Risk: What Cardiovascular Outcomes Trials Tell Us About Incretin-Based Therapies

Advancing Secondary Stroke Prevention: How the Latest Evidence Informs Team-Based Practice

Biomarker-Driven Insights in ATTR-CM: Interpreting the Impact of the Latest Evidence

Anne K. Ellis, MD, MSc, FRCPC / Andrew Thamboo, MD, FRCSC / Meyer Balter, MD, FRCPC - Advancing CRSwNP Care: Multidisciplinary Insights on Early Detection and the Role of Biologic Therapies

Stephanie Christenson, MD, MAS - Beyond Standard Care: Enhancing Disease Control With Biologic Therapy for Eosinophilic COPD

Matthew W. Martinez, MD, FACC, FASE / Brad Mehl, MHA, ACS, RDCS, RVT, RDMS, RT(R), FASE - The Echo Quest: Conquering Real-World Hypertrophic Cardiomyopathy Cases From Diagnosis to Treatment

Pasi A. Jänne, MD, PhD - Expanding Pathways of Care for HER2-Positive Metastatic NSCLC: Beyond Mutation to Overexpression

Stella Lee, MD - Biologic Therapies for Chronic Rhinosinusitis With Nasal Polyps: Practical, Patient-Centered Perspectives for Providers

Theresa W. Guilbert, MD, MS / William Anderson, MD - Optimizing Asthma Care in Pediatrics: The Impact of Early Intervention With Biologics on Lung Function

George L. Bakris, MD - On the Path to Improved Outcomes in Cardiorenal Disease: Strategies to Address Hyperkalemia and Maintain RAASi Therapy